The Competitive Edge of Travere Therapeutics in Biotech
An examination of how Travere Therapeutics Inc. leverages its first-mover advantage to maintain a strong position in the biotech industry.
Browse the full archive, newest first.
An examination of how Travere Therapeutics Inc. leverages its first-mover advantage to maintain a strong position in the biotech industry.
A Japanese startup has submitted a request for approval of a novel drug targeting chronic kidney disease in cats, a condition that presently lacks a definitive cure.
In a significant move, Shell has acquired Canadian shale producer ARC Resources for $16 billion, aiming to enhance its production capabilities amid investor concerns about growth.
Choice Hotels International maintains a strong growth trajectory, driven by recent strategic initiatives and a focus on customer experience.
The Center for Coastal Climate Resilience at UC Santa Cruz has teamed up with The Nature Conservancy to create a new funding tool aimed at supporting wetland restoration projects for climate adaptation.
FIGS has reported a strong financial performance in the first quarter, contributing to its positive momentum.